SCHEMBL6428043

SCHEMBL6428043

CCN(c1ccccc1)S(=O)(=O)c1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.77
TSHR P16473 2/20 0.77
MAPK1 P28482 2/20 0.77
KMT2A Q03164 1/20 0.77
HSD17B10 Q99714 1/20 0.77
NR1I2 O75469 2/20 0.69
RORC P51449 2/20 0.63
RORA P35398 1/20 0.63
NR1H2 P55055 1/20 0.63
NR1H3 Q13133 1/20 0.63
RORB Q92753 1/20 0.63
NR1H4 Q96RI1 1/20 0.63
ALDH1A1 P00352 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
HSD11B1 P28845 1/20 0.61
ALPL P05186 1/20 0.59
ALPI P09923 1/20 0.59
MAPT P10636 1/20 0.59
ALPG P10696 1/20 0.59
LMNA P02545 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5604160 0.89 ESR1 (0.73) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL28133849 0.89 CNR1 (0.69) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL6302204 0.88 ESR1 (0.88) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL11404947 0.88 ESR1 (0.67) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL2603075 0.88 ESR1 (0.71) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL10904389 0.88 ESR1 (1.00) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL28728523 0.85 CNR1 (0.70) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL10438567 0.85 ESR1 (0.79) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL6297282 0.84 ESR1 (0.70) ESR1TSHRMAPK1KMT2AHSD17B10
SCHEMBL5467499 0.84 ESR1 (0.58) ESR1TSHRMAPK1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439252-B2 Electrolyte solution for electrochemical device, and electrochemical device FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-08 US disclosed
US-10022376-B2 Pyrazolopyridines and pyrazolopyrimidines PFIZER INC. (US) 2018-07-17 US disclosed
US-20170071946-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. (US) 2017-03-16 US disclosed
US-9518052-B2 Pyrazolopyridines and pyrazolopyrimidines PFIZER INC. (US) 2016-12-13 US disclosed
US-20150364792-A1 ELECTROLYTE SOLUTION FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2015-12-17 US disclosed
US-20150329542-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES PFIZER INC. 2015-11-19 US disclosed
US-6967196-B1 Sulfonamide compounds and uses thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2005-11-22 US disclosed
US-6818367-B2 A BENZOXAZOLE EASTMAN KODAK COMPANY 2004-11-16 US disclosed
US-20040209180-A1 SUPPORT WITH REDUCED OPTICAL BRIGHTENER MIGRATION BANK OF AMERICA, N.A., AS AGENT 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10022376-B2 Pyrazolopyridines and pyrazolopyrimidines CBR3, HRH4, REN ESR1 2887/4885TSHR 330/4885MAPK1 2646/4885
US-20150329542-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES HRH2, HRH4, HRH1 ESR1 3247/4885TSHR 85/4885MAPK1 3196/4885
US-20170071946-A1 PYRAZOLOPYRIDINES AND PYRAZOLOPYRIMIDINES HRH2, HRH4, HRH1 ESR1 3247/4885TSHR 85/4885MAPK1 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.